Cloprednol

DB13843InvestigationalSmall molecule

Cloprednol is a glucocorticoid indicated in the treatment of arthritis and asthma. A medication used to treat arthritis and asthma.

Mechanism: Cloprednol is a synthetic glucocorticoid. Glucocorticoids act by binding the glucocorticoid receptor, which alters transcription of inflammatory and immune genes.
Curator reviewed · 1 reference
Formula / weight: C₂₁H₂₅ClO₅ · 392.88 g/mol (avg)
Code names: RS-4691

Resolves to

Compound

UNIISYP56O3GJGCAS5251-34-3ChEMBLCHEMBL1697832ChEBI135619KEGGD03561

Clinical / RWD

RxNorm21285ATCH02AB14

Structure

InChIKeyYTJIBEDMAQUYSZ-FDNPDPBUSA-NSMILES[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@]([H])(O)[C@@]1([H])[C@@]2([H])C=C(Cl)C2=CC(=O)C=C[C@]12C

Targets

P04150NR3C1

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,203Drug interactionsStructured to mechanism, not free text

3Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

4Marketed productsAcross every region we cover

1ATC codeIncluding every combination product, plus 18 drug categories

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cloprednol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account